Logo image of CHCI

COMSTOCK HOLDING COMPANIES (CHCI) Stock Fundamental Analysis

NASDAQ:CHCI - Nasdaq - US2056842022 - Common Stock - Currency: USD

7.1004  +0.09 (+1.29%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to CHCI. CHCI was compared to 64 industry peers in the Real Estate Management & Development industry. CHCI has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. CHCI is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

9

1. Profitability

1.1 Basic Checks

CHCI had positive earnings in the past year.
CHCI had a positive operating cash flow in the past year.
In the past 5 years CHCI has always been profitable.
CHCI had a positive operating cash flow in each of the past 5 years.
CHCI Yearly Net Income VS EBIT VS OCF VS FCFCHCI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M -10M

1.2 Ratios

CHCI has a Return On Assets of 11.70%. This is amongst the best in the industry. CHCI outperforms 100.00% of its industry peers.
CHCI's Return On Equity of 14.64% is amongst the best of the industry. CHCI outperforms 98.44% of its industry peers.
CHCI's Return On Invested Capital of 13.39% is amongst the best of the industry. CHCI outperforms 98.44% of its industry peers.
CHCI had an Average Return On Invested Capital over the past 3 years of 17.96%. This is significantly above the industry average of 5.31%.
The 3 year average ROIC (17.96%) for CHCI is well above the current ROIC(13.39%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 11.7%
ROE 14.64%
ROIC 13.39%
ROA(3y)22.97%
ROA(5y)16.15%
ROE(3y)35.73%
ROE(5y)27.33%
ROIC(3y)17.96%
ROIC(5y)15.67%
CHCI Yearly ROA, ROE, ROICCHCI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 200 300

1.3 Margins

The Profit Margin of CHCI (13.44%) is better than 89.06% of its industry peers.
CHCI's Profit Margin has improved in the last couple of years.
CHCI's Operating Margin of 15.74% is amongst the best of the industry. CHCI outperforms 85.94% of its industry peers.
CHCI's Operating Margin has improved in the last couple of years.
CHCI has a Gross Margin (21.03%) which is in line with its industry peers.
In the last couple of years the Gross Margin of CHCI has grown nicely.
Industry RankSector Rank
OM 15.74%
PM (TTM) 13.44%
GM 21.03%
OM growth 3Y19.53%
OM growth 5Y62.13%
PM growth 3Y23.09%
PM growth 5YN/A
GM growth 3Y13.68%
GM growth 5Y31.25%
CHCI Yearly Profit, Operating, Gross MarginsCHCI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40

More info and screens

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CHCI is creating value.
The number of shares outstanding for CHCI has been increased compared to 1 year ago.
The number of shares outstanding for CHCI has been increased compared to 5 years ago.
There is no outstanding debt for CHCI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CHCI Yearly Shares OutstandingCHCI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M
CHCI Yearly Total Debt VS Total AssetsCHCI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

2.2 Solvency

Based on the Altman-Z score of 1.53, we must say that CHCI is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.53, CHCI is in line with its industry, outperforming 53.13% of the companies in the same industry.
There is no outstanding debt for CHCI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 1.53
ROIC/WACC1.49
WACC8.96%
CHCI Yearly LT Debt VS Equity VS FCFCHCI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M 30M

2.3 Liquidity

CHCI has a Current Ratio of 2.88. This indicates that CHCI is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.88, CHCI is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
A Quick Ratio of 2.88 indicates that CHCI has no problem at all paying its short term obligations.
CHCI has a better Quick ratio (2.88) than 79.69% of its industry peers.
Industry RankSector Rank
Current Ratio 2.88
Quick Ratio 2.88
CHCI Yearly Current Assets VS Current LiabilitesCHCI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for CHCI have decreased strongly by -16.20% in the last year.
The Earnings Per Share has been growing by 45.50% on average over the past years. This is a very strong growth
CHCI shows a small growth in Revenue. In the last year, the Revenue has grown by 5.34%.
CHCI shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 22.22% yearly.
EPS 1Y (TTM)-16.2%
EPS 3Y45.5%
EPS 5YN/A
EPS Q2Q%-49.98%
Revenue 1Y (TTM)5.34%
Revenue growth 3Y25.73%
Revenue growth 5Y22.22%
Sales Q2Q%-10.38%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHCI Yearly Revenue VS EstimatesCHCI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
CHCI Yearly EPS VS EstimatesCHCI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 11.83, the valuation of CHCI can be described as very reasonable.
Based on the Price/Earnings ratio, CHCI is valued cheaper than 90.63% of the companies in the same industry.
CHCI is valuated cheaply when we compare the Price/Earnings ratio to 29.35, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 11.83
Fwd PE N/A
CHCI Price Earnings VS Forward Price EarningsCHCI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

95.31% of the companies in the same industry are more expensive than CHCI, based on the Enterprise Value to EBITDA ratio.
CHCI's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CHCI is cheaper than 93.75% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.82
EV/EBITDA 6.66
CHCI Per share dataCHCI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

The excellent profitability rating of CHCI may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CHCI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

COMSTOCK HOLDING COMPANIES

NASDAQ:CHCI (3/7/2025, 8:13:22 PM)

7.1004

+0.09 (+1.29%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)11-13 2024-11-13/amc
Earnings (Next)03-26 2025-03-26
Inst Owners7.54%
Inst Owner Change-0.69%
Ins Owners65.64%
Ins Owner Change1.17%
Market Cap70.22M
Analysts0
Price TargetN/A
Short Float %0.3%
Short Ratio0.7
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 11.83
Fwd PE N/A
P/S 1.55
P/FCF 5.82
P/OCF 5.71
P/B 1.68
P/tB 1.69
EV/EBITDA 6.66
EPS(TTM)0.6
EY8.45%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.22
FCFY17.17%
OCF(TTM)1.24
OCFY17.53%
SpS4.59
BVpS4.22
TBVpS4.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 11.7%
ROE 14.64%
ROCE 16.95%
ROIC 13.39%
ROICexc 26.75%
ROICexgc 26.96%
OM 15.74%
PM (TTM) 13.44%
GM 21.03%
FCFM 26.55%
ROA(3y)22.97%
ROA(5y)16.15%
ROE(3y)35.73%
ROE(5y)27.33%
ROIC(3y)17.96%
ROIC(5y)15.67%
ROICexc(3y)33.58%
ROICexc(5y)27.55%
ROICexgc(3y)33.78%
ROICexgc(5y)29.13%
ROCE(3y)22.73%
ROCE(5y)21.64%
ROICexcg growth 3Y14.48%
ROICexcg growth 5Y117.95%
ROICexc growth 3Y21.59%
ROICexc growth 5Y120.25%
OM growth 3Y19.53%
OM growth 5Y62.13%
PM growth 3Y23.09%
PM growth 5YN/A
GM growth 3Y13.68%
GM growth 5Y31.25%
F-Score5
Asset Turnover0.87
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 109.57%
Cap/Sales 0.56%
Interest Coverage 250
Cash Conversion 166.82%
Profit Quality 197.54%
Current Ratio 2.88
Quick Ratio 2.88
Altman-Z 1.53
F-Score5
WACC8.96%
ROIC/WACC1.49
Cap/Depr(3y)205.5%
Cap/Depr(5y)183.3%
Cap/Sales(3y)0.91%
Cap/Sales(5y)0.79%
Profit Quality(3y)82.72%
Profit Quality(5y)263.28%
High Growth Momentum
Growth
EPS 1Y (TTM)-16.2%
EPS 3Y45.5%
EPS 5YN/A
EPS Q2Q%-49.98%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.34%
Revenue growth 3Y25.73%
Revenue growth 5Y22.22%
Sales Q2Q%-10.38%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-18.77%
EBIT growth 3Y50.28%
EBIT growth 5Y98.15%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y115.29%
FCF growth 3Y38.44%
FCF growth 5Y-7.46%
OCF growth 1Y95.37%
OCF growth 3Y38.35%
OCF growth 5Y-6.94%